Head-to-head · Value Score
Vitara RX vs Primary Clinic (Direct GLP)
Two GLP-1 deals, scored on the same six factors. Vitara RX lands a Value Score of 91, Primary Clinic (Direct GLP) a 70. Here's who gives you the honest lower price — and where each one bites back.
Vitara RX
#4 · Grade A · Best Value
Est. first month
$99/mo
Save ~93% vs brand-namePrimary Clinic (Direct GLP)
#221 · Grade C · Watch List
Est. first month
From $85/mo (0.25-0.75 mg band, membership required, compounded)
Save ~87% vs brand-nameThe verdict
Vitara RX takes it on Value Score, 91 to 70 — an est. $99/mo first month, with no teaser step-up baked in. Primary Clinic (Direct GLP) isn't out of it: Shoppers in one of the 10 covered states who want unlimited primary care bundled with their GLP-1 and will pay a membership to get wholesale drug pricing.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | Vitara RX | Primary Clinic (Direct GLP) |
|---|---|---|
| Value Score | 91 (A) | 70 (C) |
| Est. first month | $99/mo | From $85/mo (0.25-0.75 mg band, membership required, compounded) |
| Save vs brand-name | ~93% | ~87% |
| Semaglutide | $99/mo | From $85/mo (0.25-0.75 mg band, membership required, compounded) |
| Tirzepatide | $149/mo | From $133/mo (1.25-2.5 mg band, membership required, compounded) |
| Both molecules | Yes | Yes |
| Pricing | Flat — no step-up | Watch |
| Coverage | 49 states | 10 states (WA, NM, AZ, UT, FL, DC, KS, OK, VA, GA) |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
Vitara RX
VitaraRx is a direct-to-consumer telehealth marketplace offering compounded semaglutide and tirzepatide at flat per-drug pricing across all doses — no membership or hidden fees.
Why it's a deal
- Among the lowest flat pricing in the market — $99/mo semaglutide and $149/mo tirzepatide, all doses same price
- Names its 503A pharmacy partner (Manifest Pharmacy, Greer SC) — strong supply-chain transparency
- LegitScript Certified
- Publishes the FDA compounded-medication disclaimer
- Covers 49 states with an explicit state list, not vague "most states" language
The fine print
- No corporate legal entity disclosed — only the trade name "VitaraRx"
- No named medical director — all clinical decisions made by independent providers (marketplace model)
- All sales final — no medication returns
- Per-vial mg quantity isn't clearly disclosed, making price comparisons harder
- Doesn't ship to Alaska
Primary Clinic (Direct GLP)
A 10-state direct-primary-care clinic selling GLP-1s at wholesale to its own members — cheap per milligram, but only on top of an $89/mo membership.
Why it's a deal
- Medication is billed at the clinic's wholesale cost with no markup, and the whole dose ladder is published rather than hidden behind intake
- The $89 membership also covers unlimited primary care, routine labs and prescription management, not GLP-1 care alone
The fine print
- The medication price sits on top of an $89/mo membership which the site's own FAQ states does NOT include the drug — about $174/mo all-in for semaglutide and $222/mo for tirzepatide
- Prices are published as dose BANDS and step up steeply as you titrate: semaglutide runs $85, $108, $145 then $183, so the entry figure is not what a maintenance dose costs
- The entire catalog renders only in JavaScript — the served HTML body is empty, so nothing is readable without running the site's bundle
- Only 10 states, small clinic, and not LegitScript-certified
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.
Neither one the right fit? Every program that outscores Vitara RX is ranked on the Vitara RX alternatives ranking, and the same list for the other side is on alternatives to Primary Clinic (Direct GLP).
More head-to-heads
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.